Tarsus Pharmaceuticals, Inc. (TARS)
61.27
-0.28
(-0.45%)
USD |
NASDAQ |
Jun 10, 16:00
61.80
+0.53
(+0.87%)
Pre-Market: 08:59
Tarsus Pharmaceuticals Shareholders Equity (Quarterly) : 348.95M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 348.95M |
| December 31, 2025 | 343.43M |
| September 30, 2025 | 335.08M |
| June 30, 2025 | 332.61M |
| March 31, 2025 | 342.46M |
| December 31, 2024 | 224.53M |
| September 30, 2024 | 237.48M |
| June 30, 2024 | 252.25M |
| March 31, 2024 | 275.21M |
| December 31, 2023 | 196.99M |
| September 30, 2023 | 213.66M |
| June 30, 2023 | 147.73M |
| March 31, 2023 | 173.40M |
| Date | Value |
|---|---|
| December 31, 2022 | 192.90M |
| September 30, 2022 | 202.63M |
| June 30, 2022 | 221.50M |
| March 31, 2022 | 149.20M |
| December 31, 2021 | 166.73M |
| September 30, 2021 | 179.14M |
| June 30, 2021 | 192.47M |
| March 31, 2021 | 183.23M |
| December 31, 2020 | 165.98M |
| September 30, 2020 | 85.33M |
| June 30, 2020 | 52.37M |
| March 31, 2020 | |
| December 31, 2019 | 57.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Structure Therapeutics, Inc. | 1.447B |
| Eton Pharmaceuticals, Inc. | 30.62M |
| Alumis, Inc. | 567.02M |
| Veradermics, Inc. | 391.87M |
| ANI Pharmaceuticals, Inc. | 562.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 581.14M |
| Total Liabilities (Quarterly) | 232.18M |
| Debt to Equity Ratio | 0.2541 |
| Current Ratio | 3.744 |
| Net Debt Paydown Yield | -0.11% |